ArticleScientific reports2026
AAV-only targeting of ventral tegmental area dopamine neurons for optical self-stimulation studies in mice.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Optogenetic studies in rodents have highlighted the importance of ventral tegmental area (VTA) dopamine (DA) neurons to reward, learning, and motivation. Selective manipulation of VTA DA neurons is generally achieved with transgenic rodent lines that use a DA neuron-specific promoter to express Cre recombinase, combined with intra-VTA infusion of adeno-associated virus (AAV) vectors harboring Cre-dependent expression cassettes. These studies incur expenses related to line acquisition and husbandry and are typically rate-limited by in-house breeding capacity. Here, we describe a dual AAV approach that permits genetic access to VTA DA neurons and supports robust optical self-stimulation in mice. One vector employs a mouse tyrosine hydroxylase (TH) promoter fragment to drive Cre expression (AAV8-mTH-Cre). Intra-VTA co-infusion of AAV8-mTH-Cre with another vector harboring a Cre-dependent reporter labeled TH-positive VTA neurons in C57BL/6J mice with an efficiency (82%) and selectivity/fidelity (73%) comparable to studies involving TH-Cre knock-in mice. Co-infusion of AAV8-mTH-Cre with a Cre-dependent channelrhodopsin (ChR2) expression vector permitted optical regulation of VTA neurons exhibiting electrophysiological features consistent with conventional DA neurons and supported robust optical self-stimulation. Thus, this AAV-only approach allows investigation of reward-related behavior when transgenic Cre lines are not available, and in studies involving mutant mouse lines or inbred mouse strains.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.